Zynyz™ (retifanlimab-dlwr) – New drug approval
March 22, 2023 - Incyte announced the FDA approval of Zynyz (retifanlimab-dlwr), for the treatment of adult patients with metastatic or recurrent locally advanced Merkel cell carcinoma (MCC).
Download PDF
